Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/1998
12/22/1998US5852210 Cinnamic acid derivatives
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852024 Treatment and prevention of adhesions
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5851986 Promoting bone formation and inhibiting bone resorption with high mobility group protein-1 (HMG-1)
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056788A1 Imidazolyl-cyclic acetals
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998CA2293363A1 Secreted proteins and polynucleotides encoding them
12/16/1998EP0883404A1 Combination therapy for osteoporosis
12/16/1998EP0883402A1 Novel cycloalkyl substituded imidazoles
12/16/1998CN1201685A Ginkgo and calcium capsule
12/16/1998CN1201677A Oral liquor for would and preparation thereof
12/16/1998CN1041203C Preparation of pyrazolopyridine compound
12/15/1998US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849726 Anhydrous alendronate monosodium salt formulations
12/15/1998US5849692 Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
12/15/1998US5849336 Method using sturgeon notochord for alleviating the symptoms of arthritis
12/15/1998US5849283 Human interleukin-6 receptor antagonists
12/15/1998CA2163667C Imidazole lipoxygenase inhibitors
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055604A1 Hydrophilic composition containing protease produced by vibrio
12/10/1998WO1998055499A1 11β-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998WO1998055439A1 Indane compounds and their pharmaceutical use
12/10/1998WO1998055124A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/10/1998WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055114A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
12/10/1998WO1998030590A3 Analogs of parathyroid hormone
12/10/1998CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292525A1 11.beta.-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments
12/10/1998CA2260861A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998EP0881908A1 Use of fibroblast growth factors to stimulate bone growth
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998CN1201392A Pentacyclic compounds, intermediates, preparation process, compositions and methods thereof
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5846931 Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide and methods of inducing cartilage by administration of same
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054207A1 Anti-inflammatory tyrosine derivatives
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054180A1 Novel compounds
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19724187A1 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln 11beta-aryl-substituted 14,17-ethanoestratrienes, processes for preparing these compounds, and their use for the preparation of medicaments
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0880529A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880528A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880511A1 Integrin receptor antagonists
12/02/1998EP0880366A1 SKIN-ADHERING PHARMACEUTICAL PREPARATION, IN PARTICULAR TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL TO THE HUMAN ORGANISM
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/02/1998CN1200295A Quick action powder medicine for reunion of broken bone
12/02/1998CN1200288A Tung oil plaster for reinforcing muscles and strengthening bones
12/02/1998CN1200284A Patent traditional Chinese medicine for treating cervical vertebra disease
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843984 Sulfated benzothiophene derivatives, methods of use and formulations containing same
12/01/1998US5843963 Benzothiophene compounds, intermediates, processes, compositions, and methods
12/01/1998US5843947 N-pyridyl carboxamides and derivatives
12/01/1998US5843940 Benzothiophene compounds, compositions, and method
12/01/1998US5843928 2-alkylidene-19-nor-vitamin D compounds
12/01/1998US5843927 18,19-dinor-vitamin D compounds
12/01/1998US5843924 Intravenous alendronate formulations
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843678 Osteoprotegerin binding proteins
11/1998
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 820